CRISPR-Cas9 Craze
Crispr News
-
Physicist uses intuition, supercomputers to identify new high-temperature superconductor — ScienceDaily - Verve TimesMay 25, 2022
-
Researchers use CRISPR technology to modify starches in potatoes - Phys.orgMay 25, 2022
-
Where Does Wall Street Think Crispr Therapeutics AG (CRSP) Stock Will Go? - InvestorsObserverMay 25, 2022
-
Plant Breeding and CRISPR Plants Market Size And Forecast | Bayer, Syngenta, KWS, DowDuPont, Eurofins, SGS, Advanta Seeds, Benson Hill Biosystems, Bioconsortia, DLF – The Daily Vale - The Daily ValeMay 25, 2022
-
On the record – modified bacteria can capture gut health status - Longevity.TechnologyMay 25, 2022
-
Cell Theraputics Market Share and Size 2022 By Type, By Application, and By Region | Key Players Quanterix, PTC Therapeutics, Moderna Therapeutics, Lineage Cell Therapeutics, Cti Biopharma, Crispr Therapeutics, Bluebird Bio – The Daily Vale - The Daily ValeMay 25, 2022
-
CRISPR-PE Technology Market Research With Beam Therapeutics, CRISPR Therapeutics, GenScript Biotech, Horizon Discovery, Integrated DNA Technologies (IDT | Cumulative Report 2022 Impact of COVID-28 – The Daily Vale - The Daily ValeMay 25, 2022
-
Breakthrough CRISPR-Combo edits some genes and activates others - New AtlasMay 25, 2022
-
Gene Editing Service Market Increasing Demand and Dynamic Growth with Forecast 2029 | BBI Life Sciences, Bio Basic, CRISPR Therapeutics, Caribou Biosciences, DNA 2.0 (ATUM) – The Daily Vale - The Daily ValeMay 25, 2022
-
UK uses Brexit freedom to speed up the development of 'gene-edited' crops and livestock - Daily MailMay 24, 2022
-
Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Technology Market Size And Forecast | Thermo Fisher Scientific, Merck, GenScript, Integrated DNA Technologies, Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia, - The Daily ValeMay 24, 2022
-
Goldman Sachs Maintains Neutral on CRISPR Therapeutics, Lowers Price Target to $46 - Benzinga - BenzingaMay 24, 2022
-
CRISPR tomatoes genetically engineered to be richer in vitamin D - New AtlasMay 24, 2022
-
Gene Editing Service Market Size 2022 Overview by 2029 | Key Players – BBI Life Sciences, Bio Basic, CRISPR Therapeutics, Caribou Biosciences, DNA 2.0 (ATUM) – The Daily Vale - The Daily ValeMay 24, 2022
-
CRISPR Editing Accidentally Turns Hamsters Into Angry Bullies - IFLScienceMay 23, 2022
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.